Citizen Petition from Americans for Scientific Integrity

An individual is submitting a comment in support of a request for a precautionary neurodevelopmental warning regarding acetaminophen use in infants and young children. The commenter provides a book as a source guide and synthesis of scientific literature regarding the risks of acetaminophen exposure during early brain development.

Allan Peter Davis, representing North Carolina State University, provides toxicogenomic data from the Comparative Toxicogenomics Database (CTD) and AOP-Wiki to support the petition for a pediatric neurodevelopmental warning for acetaminophen. The comment highlights that acetaminophen is a top-ranked chemical association for Autistic Disorder and interacts with multiple biological events in an autism-related adverse outcome pathway.

The Consumer Healthcare Products Association (CHPA) opposes the citizen petition requesting new neurodevelopmental warning language for OTC acetaminophen products. They argue that the petition fails to provide credible evidence of a causal link between postnatal acetaminophen use and autism or other neurodevelopmental outcomes, citing existing scientific literature and regulatory standards.

Americans for Scientific Integrity submitted a Bayesian weight-of-evidence analysis to support their citizen petition for precautionary pediatric acetaminophen warnings. They argue that cumulative evidence from epidemiology, animal models, and biomarkers suggests a risk of neurodevelopmental harm in susceptible children.

An anonymous commenter supports the proposed action of adding precautionary warnings to pediatric acetaminophen labels. They argue that current safety assessments focus too heavily on liver toxicity and should instead include warnings about potential non-hepatic risks, such as reproductive, developmental, and pulmonary effects.

The commenter supports the Americans for Scientific Integrity citizen petition for a precautionary pediatric acetaminophen warning. They argue that sibling-control analyses in prenatal studies are methodologically flawed and should not be used as definitive evidence to dismiss potential neurodevelopmental risks.

The commenter cites a new study on rodent models showing that in utero exposure to acetaminophen can cause brainstem impairment and neuron loss in offspring. They argue that these findings support the need for both pregnancy and pediatric warnings to ensure informed use during early-life development.

WPLab, Inc., a non-profit organization, provides research and educational materials to support the petition by arguing that acetaminophen exposure in infants and children is a primary cause of autism. They advocate for public education on the risks of the drug and the promotion of non-pharmacological alternatives for managing pain and fevers.

Americans for Scientific Integrity supports the request for precautionary pediatric warnings regarding acetaminophen use in young children. They argue that because detoxification pathways are immature in early childhood, exposure shortly after birth may be as biologically relevant as prenatal exposure, and they cite studies showing structural brain differences and neurodevelopmental risks.

The provided text is a collection of various documents, including a legal filing regarding a lawsuit against Kenvue Brands LLC, an internal FDA memorandum regarding acetaminophen and ADHD, and several FDA news releases and health bulletins. It does not contain a specific public comment submitted in response to the "Citizen Petition from Americans for Scientific Integrity."